Skip to content
About
Services
Resources
Contact
Open Search
Search
About
Services
Resources
Contact
Open Search
Close Menu
Scientific Paper
Scientific Paper
NYX-458 Improves Cognitive Performance in a Primate Parkinson’s Disease Model
April 27, 2023
Scientific Paper
Exosome markers of LRRK2 kinase inhibition
April 27, 2023
Scientific Paper
Repurposing drugs to treat L-DOPA-induced dyskinesia in Parkinson’s disease
April 27, 2023
Scientific Paper
Pharmacokinetic/Pharmacodynamic Correlation Analysis of Amantadine for Levodopa-Induced Dyskinesia
April 27, 2023
Scientific Paper
Pridopidine, a Clinic-Ready Compound, Reduces 3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Parkinsonian Macaques
April 27, 2023
Scientific Paper
Subthalamic Nucleus Deep Brain Stimulation Is Neuroprotective in the A53T a-Synuclein Parkinson’s Disease Rat Model
April 27, 2023
Scientific Paper
DPI-289, a novel mixed delta opioid agonist / mu opioid antagonist (DAMA), has L-DOPA-sparing potential in Parkinson’s disease
April 27, 2023
Scientific Paper
AAV1/2-induced overexpression of A53T-αsynuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment…
April 27, 2023
Scientific Paper
Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism
April 27, 2023
Scientific Paper
Animal models of α‑synucleinopathy for Parkinson disease drug development
April 27, 2023
Posts navigation
Previous
1
2
3
…
7
Next
At Atuka, we combine our capabilities with yours to harness the power of partnership and advance your therapeutic program.
Talk to a Neuroscience Expert
Scroll Up